Triphenyl(pyridin-2-ylmethyl)phosphonium bromide, 97%, 1g

Thalidomide-O-amido-C8-NH2 (TFA), 500mg

Microliter syringe MICROLITER® series 7000 Point type 2, 0.5 µl, 7000.5 KH, 1 Piece

Mixing cylinders class A, 50 ml, 2 Piece(s)

(3R,4R)-3-(2,2-Dibromoethenyl)-4-methyl-4-[2-(triethylsilyl)ethynyl]cyclohexene, 100mg

6-Bromo-2-methoxynicotinonitrile, 95.0%, 1g

(Z)-4-((4-hydroxyphenyl)amino)-4-oxobut-2-enoic acid, 97%, 1g

6-Nitroquinoxaline, 95.0%, 100g

3-(4-Fluoro-phenylsulfanylmethyl)-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

2-Ethyl-2,8-diazaspiro[4.5]decan-3-one, 97.0%, 100mg

N,N'-(Ethane-1,2-diyl)bis(1-phenylmethanimine), 95%, 5g

[(1S)-1-phenylethyl](propan-2-yl)amine, 95.0%, 500mg

5-Amino-1H-pyrazole-4-carboxylic acid ethyl ester, 97.0%, 500g